GO Annotation
| Category | Term ID | Term description |
|---|---|---|
| Process | GO:0000302 | Response to reactive oxygen species |
| Process | GO:0001666 | Response to hypoxia |
| Process | GO:0001775 | Cell activation |
| Process | GO:0001817 | Regulation of cytokine production |
| Process | GO:0001819 | Positive regulation of cytokine production |
| Process | GO:0002200 | Somatic diversification of immune receptors |
| Process | GO:0002204 | Somatic recombination of immunoglobulin genes involved in immune response |
| Process | GO:0002208 | Somatic diversification of immunoglobulins involved in immune response |
| Process | GO:0002221 | Pattern recognition receptor signaling pathway |
| Process | GO:0002224 | Toll-like receptor signaling pathway |
| Process | GO:0002237 | Response to molecule of bacterial origin |
| Process | GO:0002250 | Adaptive immune response |
| Process | GO:0002252 | Immune effector process |
| Process | GO:0002263 | Cell activation involved in immune response |
| Process | GO:0002285 | Lymphocyte activation involved in immune response |
| Process | GO:0002312 | B cell activation involved in immune response |
| Process | GO:0002366 | Leukocyte activation involved in immune response |
| Process | GO:0002376 | Immune system process |
| Process | GO:0002377 | Immunoglobulin production |
| Process | GO:0002381 | Immunoglobulin production involved in immunoglobulin-mediated immune response |
| Process | GO:0002440 | Production of molecular mediator of immune response |
| Process | GO:0002443 | Leukocyte mediated immunity |
| Process | GO:0002449 | Lymphocyte mediated immunity |
| Process | GO:0002460 | Adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains |
| Process | GO:0002520 | Immune system development |
| Process | GO:0002562 | Somatic diversification of immune receptors via germline recombination within a single locus |
| Process | GO:0002682 | Regulation of immune system process |
| Process | GO:0002684 | Positive regulation of immune system process |
| Process | GO:0002694 | Regulation of leukocyte activation |
| Process | GO:0002696 | Positive regulation of leukocyte activation |
| Process | GO:0002697 | Regulation of immune effector process |
| Process | GO:0002699 | Positive regulation of immune effector process |
| Process | GO:0002703 | Regulation of leukocyte mediated immunity |
| Process | GO:0002705 | Positive regulation of leukocyte mediated immunity |
| Process | GO:0002706 | Regulation of lymphocyte mediated immunity |
| Process | GO:0002708 | Positive regulation of lymphocyte mediated immunity |
| Process | GO:0002709 | Regulation of T cell mediated immunity |
| Process | GO:0002711 | Positive regulation of T cell mediated immunity |
| Process | GO:0002755 | MyD88-dependent toll-like receptor signaling pathway |
| Process | GO:0002764 | Immune response-regulating signaling pathway |
| Process | GO:0002819 | Regulation of adaptive immune response |
| Process | GO:0002821 | Positive regulation of adaptive immune response |
| Process | GO:0002822 | Regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains |
| Process | GO:0002824 | Positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains |
| Process | GO:0002831 | Regulation of response to biotic stimulus |
| Process | GO:0002833 | Positive regulation of response to biotic stimulus |
| Process | GO:0002834 | Regulation of response to tumor cell |
| Process | GO:0002836 | Positive regulation of response to tumor cell |
| Process | GO:0002837 | Regulation of immune response to tumor cell |
| Process | GO:0002839 | Positive regulation of immune response to tumor cell |
| Process | GO:0002840 | Regulation of T cell mediated immune response to tumor cell |
| Process | GO:0002842 | Positive regulation of T cell mediated immune response to tumor cell |
| Process | GO:0002931 | Response to ischemia |
| Process | GO:0006139 | Nucleobase-containing compound metabolic process |
| Process | GO:0006259 | DNA metabolic process |
| Process | GO:0006310 | DNA recombination |
| Process | GO:0006457 | Protein folding |
| Process | GO:0006458 | De novo protein folding |
| Process | GO:0006605 | Protein targeting |
| Process | GO:0006626 | Protein targeting to mitochondrion |
| Process | GO:0006725 | Cellular aromatic compound metabolic process |
| Process | GO:0006807 | Nitrogen compound metabolic process |
| Process | GO:0006810 | Transport |
| Process | GO:0006839 | Mitochondrial transport |
| Process | GO:0006886 | Intracellular protein transport |
| Process | GO:0006915 | Apoptotic process |
| Process | GO:0006919 | Activation of cysteine-type endopeptidase activity involved in apoptotic process |
| Process | GO:0006950 | Response to stress |
| Process | GO:0006955 | Immune response |
| Process | GO:0006979 | Response to oxidative stress |
| Process | GO:0006986 | Response to unfolded protein |
| Process | GO:0006996 | Organelle organization |
| Process | GO:0007005 | Mitochondrion organization |
| Process | GO:0007154 | Cell communication |
| Process | GO:0007165 | Signal transduction |
| Process | GO:0007275 | Multicellular organism development |
| Process | GO:0008104 | Protein localization |
| Process | GO:0008152 | Metabolic process |
| Process | GO:0008219 | Cell death |
| Process | GO:0008283 | Cell population proliferation |
| Process | GO:0008637 | Apoptotic mitochondrial changes |
| Process | GO:0009266 | Response to temperature stimulus |
| Process | GO:0009408 | Response to heat |
| Process | GO:0009409 | Response to cold |
| Process | GO:0009410 | Response to xenobiotic stimulus |
| Process | GO:0009605 | Response to external stimulus |
| Process | GO:0009607 | Response to biotic stimulus |
| Process | GO:0009617 | Response to bacterium |
| Process | GO:0009628 | Response to abiotic stimulus |
| Process | GO:0009719 | Response to endogenous stimulus |
| Process | GO:0009725 | Response to hormone |
| Process | GO:0009889 | Regulation of biosynthetic process |
| Process | GO:0009890 | Negative regulation of biosynthetic process |
| Process | GO:0009892 | Negative regulation of metabolic process |
| Process | GO:0009893 | Positive regulation of metabolic process |
| Process | GO:0009987 | Cellular process |
| Process | GO:0010033 | Response to organic substance |
| Process | GO:0010035 | Response to inorganic substance |
| Process | GO:0010243 | Response to organonitrogen compound |
| Process | GO:0010467 | Gene expression |
| Process | GO:0010468 | Regulation of gene expression |
| Process | GO:0010604 | Positive regulation of macromolecule metabolic process |
| Process | GO:0010628 | Positive regulation of gene expression |
| Process | GO:0010941 | Regulation of cell death |
| Process | GO:0010942 | Positive regulation of cell death |
| Process | GO:0010950 | Positive regulation of endopeptidase activity |
| Process | GO:0010952 | Positive regulation of peptidase activity |
| Process | GO:0012501 | Programmed cell death |
| Process | GO:0014070 | Response to organic cyclic compound |
| Process | GO:0014074 | Response to purine-containing compound |
| Process | GO:0014823 | Response to activity |
| Process | GO:0015031 | Protein transport |
| Process | GO:0016043 | Cellular component organization |
| Process | GO:0016064 | Immunoglobulin mediated immune response |
| Process | GO:0016444 | Somatic cell DNA recombination |
| Process | GO:0016445 | Somatic diversification of immunoglobulins |
| Process | GO:0016447 | Somatic recombination of immunoglobulin gene segments |
| Process | GO:0019222 | Regulation of metabolic process |
| Process | GO:0019724 | B cell mediated immunity |
| Process | GO:0022407 | Regulation of cell-cell adhesion |
| Process | GO:0022409 | Positive regulation of cell-cell adhesion |
| Process | GO:0023052 | Signaling |
| Process | GO:0030155 | Regulation of cell adhesion |
| Process | GO:0030162 | Regulation of proteolysis |
| Process | GO:0031323 | Regulation of cellular metabolic process |
| Process | GO:0031324 | Negative regulation of cellular metabolic process |
| Process | GO:0031347 | Regulation of defense response |
| Process | GO:0031349 | Positive regulation of defense response |
| Process | GO:0031647 | Regulation of protein stability |
| Process | GO:0031960 | Response to corticosteroid |
| Process | GO:0032101 | Regulation of response to external stimulus |
| Process | GO:0032103 | Positive regulation of response to external stimulus |
| Process | GO:0032479 | Regulation of type I interferon production |
| Process | GO:0032481 | Positive regulation of type I interferon production |
| Process | GO:0032496 | Response to lipopolysaccharide |
| Process | GO:0032501 | Multicellular organismal process |
| Process | GO:0032502 | Developmental process |
| Process | GO:0032647 | Regulation of interferon-alpha production |
| Process | GO:0032649 | Regulation of interferon-gamma production |
| Process | GO:0032653 | Regulation of interleukin-10 production |
| Process | GO:0032655 | Regulation of interleukin-12 production |
| Process | GO:0032675 | Regulation of interleukin-6 production |
| Process | GO:0032680 | Regulation of tumor necrosis factor production |
| Process | GO:0032727 | Positive regulation of interferon-alpha production |
| Process | GO:0032729 | Positive regulation of interferon-gamma production |
| Process | GO:0032733 | Positive regulation of interleukin-10 production |
| Process | GO:0032735 | Positive regulation of interleukin-12 production |
| Process | GO:0032755 | Positive regulation of interleukin-6 production |
| Process | GO:0032760 | Positive regulation of tumor necrosis factor production |
| Process | GO:0032943 | Mononuclear cell proliferation |
| Process | GO:0033036 | Macromolecule localization |
| Process | GO:0033198 | Response to ATP |
| Process | GO:0033365 | Protein localization to organelle |
| Process | GO:0033554 | Cellular response to stress |
| Process | GO:0033993 | Response to lipid |
| Process | GO:0034097 | Response to cytokine |
| Process | GO:0034514 | Mitochondrial unfolded protein response |
| Process | GO:0034605 | Cellular response to heat |
| Process | GO:0034620 | Cellular response to unfolded protein |
| Process | GO:0034641 | Cellular nitrogen compound metabolic process |
| Process | GO:0035966 | Response to topologically incorrect protein |
| Process | GO:0035967 | Cellular response to topologically incorrect protein |
| Process | GO:0036293 | Response to decreased oxygen levels |
| Process | GO:0042026 | Protein refolding |
| Process | GO:0042100 | B cell proliferation |
| Process | GO:0042110 | T cell activation |
| Process | GO:0042113 | B cell activation |
| Process | GO:0042220 | Response to cocaine |
| Process | GO:0042221 | Response to chemical |
| Process | GO:0042542 | Response to hydrogen peroxide |
| Process | GO:0042981 | Regulation of apoptotic process |
| Process | GO:0043030 | Regulation of macrophage activation |
| Process | GO:0043032 | Positive regulation of macrophage activation |
| Process | GO:0043065 | Positive regulation of apoptotic process |
| Process | GO:0043066 | Negative regulation of apoptotic process |
| Process | GO:0043067 | Regulation of programmed cell death |
| Process | GO:0043068 | Positive regulation of programmed cell death |
| Process | GO:0043069 | Negative regulation of programmed cell death |
| Process | GO:0043085 | Positive regulation of catalytic activity |
| Process | GO:0043170 | Macromolecule metabolic process |
| Process | GO:0043207 | Response to external biotic stimulus |
| Process | GO:0043279 | Response to alkaloid |
| Process | GO:0043280 | Positive regulation of cysteine-type endopeptidase activity involved in apoptotic process |
| Process | GO:0043281 | Regulation of cysteine-type endopeptidase activity involved in apoptotic process |
| Process | GO:0043523 | Regulation of neuron apoptotic process |
| Process | GO:0043524 | Negative regulation of neuron apoptotic process |
| Process | GO:0043627 | Response to estrogen |
| Process | GO:0044093 | Positive regulation of molecular function |
| Process | GO:0044237 | Cellular metabolic process |
| Process | GO:0044238 | Primary metabolic process |
| Process | GO:0044260 | Cellular macromolecule metabolic process |
| Process | GO:0044403 | Biological process involved in symbiotic interaction |
| Process | GO:0044419 | Biological process involved in interspecies interaction between organisms |
| Process | GO:0044743 | Protein transmembrane import into intracellular organelle |
| Process | GO:0045041 | Protein import into mitochondrial intermembrane space |
| Process | GO:0045184 | Establishment of protein localization |
| Process | GO:0045190 | Isotype switching |
| Process | GO:0045321 | Leukocyte activation |
| Process | GO:0045785 | Positive regulation of cell adhesion |
| Process | GO:0045862 | Positive regulation of proteolysis |
| Process | GO:0046483 | Heterocycle metabolic process |
| Process | GO:0046649 | Lymphocyte activation |
| Process | GO:0046651 | Lymphocyte proliferation |
| Process | GO:0046683 | Response to organophosphorus |
| Process | GO:0046907 | Intracellular transport |
| Process | GO:0048291 | Isotype switching to IgG isotypes |
| Process | GO:0048518 | Positive regulation of biological process |
| Process | GO:0048519 | Negative regulation of biological process |
| Process | GO:0048522 | Positive regulation of cellular process |
| Process | GO:0048523 | Negative regulation of cellular process |
| Process | GO:0048545 | Response to steroid hormone |
| Process | GO:0048583 | Regulation of response to stimulus |
| Process | GO:0048584 | Positive regulation of response to stimulus |
| Process | GO:0048731 | System development |
| Process | GO:0048856 | Anatomical structure development |
| Process | GO:0050727 | Regulation of inflammatory response |
| Process | GO:0050729 | Positive regulation of inflammatory response |
| Process | GO:0050776 | Regulation of immune response |
| Process | GO:0050778 | Positive regulation of immune response |
| Process | GO:0050789 | Regulation of biological process |
| Process | GO:0050790 | Regulation of catalytic activity |
| Process | GO:0050794 | Regulation of cellular process |
| Process | GO:0050821 | Protein stabilization |
| Process | GO:0050863 | Regulation of T cell activation |
| Process | GO:0050865 | Regulation of cell activation |
| Process | GO:0050867 | Positive regulation of cell activation |
| Process | GO:0050870 | Positive regulation of T cell activation |
| Process | GO:0050896 | Response to stimulus |
| Process | GO:0051171 | Regulation of nitrogen compound metabolic process |
| Process | GO:0051173 | Positive regulation of nitrogen compound metabolic process |
| Process | GO:0051179 | Localization |
| Process | GO:0051234 | Establishment of localization |
| Process | GO:0051239 | Regulation of multicellular organismal process |
| Process | GO:0051240 | Positive regulation of multicellular organismal process |
| Process | GO:0051246 | Regulation of protein metabolic process |
| Process | GO:0051247 | Positive regulation of protein metabolic process |
| Process | GO:0051249 | Regulation of lymphocyte activation |
| Process | GO:0051251 | Positive regulation of lymphocyte activation |
| Process | GO:0051336 | Regulation of hydrolase activity |
| Process | GO:0051345 | Positive regulation of hydrolase activity |
| Process | GO:0051384 | Response to glucocorticoid |
| Process | GO:0051641 | Cellular localization |
| Process | GO:0051649 | Establishment of localization in cell |
| Process | GO:0051702 | Biological process involved in interaction with symbiont |
| Process | GO:0051707 | Response to other organism |
| Process | GO:0051716 | Cellular response to stimulus |
| Process | GO:0052547 | Regulation of peptidase activity |
| Process | GO:0052548 | Regulation of endopeptidase activity |
| Process | GO:0055085 | Transmembrane transport |
| Process | GO:0060255 | Regulation of macromolecule metabolic process |
| Process | GO:0060548 | Negative regulation of cell death |
| Process | GO:0065002 | Intracellular protein transmembrane transport |
| Process | GO:0065007 | Biological regulation |
| Process | GO:0065008 | Regulation of biological quality |
| Process | GO:0065009 | Regulation of molecular function |
| Process | GO:0070482 | Response to oxygen levels |
| Process | GO:0070585 | Protein localization to mitochondrion |
| Process | GO:0070661 | Leukocyte proliferation |
| Process | GO:0070727 | Cellular macromolecule localization |
| Process | GO:0070887 | Cellular response to chemical stimulus |
| Process | GO:0071310 | Cellular response to organic substance |
| Process | GO:0071345 | Cellular response to cytokine stimulus |
| Process | GO:0071702 | Organic substance transport |
| Process | GO:0071704 | Organic substance metabolic process |
| Process | GO:0071705 | Nitrogen compound transport |
| Process | GO:0071806 | Protein transmembrane transport |
| Process | GO:0071840 | Cellular component organization or biogenesis |
| Process | GO:0071865 | Regulation of apoptotic process in bone marrow cell |
| Process | GO:0071866 | Negative regulation of apoptotic process in bone marrow cell |
| Process | GO:0072594 | Establishment of protein localization to organelle |
| Process | GO:0072655 | Establishment of protein localization to mitochondrion |
| Process | GO:0080090 | Regulation of primary metabolic process |
| Process | GO:0080134 | Regulation of response to stress |
| Process | GO:0090304 | Nucleic acid metabolic process |
| Process | GO:0098760 | Response to interleukin-7 |
| Process | GO:0098761 | Cellular response to interleukin-7 |
| Process | GO:1901214 | Regulation of neuron death |
| Process | GO:1901215 | Negative regulation of neuron death |
| Process | GO:1901360 | Organic cyclic compound metabolic process |
| Process | GO:1901698 | Response to nitrogen compound |
| Process | GO:1901700 | Response to oxygen-containing compound |
| Process | GO:1903037 | Regulation of leukocyte cell-cell adhesion |
| Process | GO:1903039 | Positive regulation of leukocyte cell-cell adhesion |
| Process | GO:1903426 | Regulation of reactive oxygen species biosynthetic process |
| Process | GO:1903427 | Negative regulation of reactive oxygen species biosynthetic process |
| Process | GO:1903555 | Regulation of tumor necrosis factor superfamily cytokine production |
| Process | GO:1903557 | Positive regulation of tumor necrosis factor superfamily cytokine production |
| Process | GO:1990542 | Mitochondrial transmembrane transport |
| Process | GO:2000116 | Regulation of cysteine-type endopeptidase activity |
| Process | GO:2000377 | Regulation of reactive oxygen species metabolic process |
| Process | GO:2000378 | Negative regulation of reactive oxygen species metabolic process |
| Process | GO:2001056 | Positive regulation of cysteine-type endopeptidase activity |
| Component | GO:0005576 | Extracellular region |
| Component | GO:0005615 | Extracellular space |
| Component | GO:0005622 | Intracellular anatomical structure |
| Component | GO:0005737 | Cytoplasm |
| Component | GO:0005739 | Mitochondrion |
| Component | GO:0005740 | Mitochondrial envelope |
| Component | GO:0005743 | Mitochondrial inner membrane |
| Component | GO:0005759 | Mitochondrial matrix |
| Component | GO:0005768 | Endosome |
| Component | GO:0005769 | Early endosome |
| Component | GO:0005777 | Peroxisome |
| Component | GO:0005782 | Peroxisomal matrix |
| Component | GO:0005783 | Endoplasmic reticulum |
| Component | GO:0005791 | Rough endoplasmic reticulum |
| Component | GO:0005794 | Golgi apparatus |
| Component | GO:0005795 | Golgi stack |
| Component | GO:0005829 | Cytosol |
| Component | GO:0005886 | Plasma membrane |
| Component | GO:0005905 | Clathrin-coated pit |
| Component | GO:0005929 | Cilium |
| Component | GO:0009986 | Cell surface |
| Component | GO:0012505 | Endomembrane system |
| Component | GO:0016020 | Membrane |
| Component | GO:0016021 | Integral component of membrane |
| Component | GO:0019866 | Organelle inner membrane |
| Component | GO:0030061 | Mitochondrial crista |
| Component | GO:0030135 | Coated vesicle |
| Component | GO:0030141 | Secretory granule |
| Component | GO:0031090 | Organelle membrane |
| Component | GO:0031224 | Intrinsic component of membrane |
| Component | GO:0031410 | Cytoplasmic vesicle |
| Component | GO:0031514 | Motile cilium |
| Component | GO:0031907 | Microbody lumen |
| Component | GO:0031966 | Mitochondrial membrane |
| Component | GO:0031967 | Organelle envelope |
| Component | GO:0031974 | Membrane-enclosed lumen |
| Component | GO:0031975 | Envelope |
| Component | GO:0031982 | Vesicle |
| Component | GO:0031984 | Organelle subcompartment |
| Component | GO:0031985 | Golgi cisterna |
| Component | GO:0032991 | Protein-containing complex |
| Component | GO:0036126 | Sperm flagellum |
| Component | GO:0042579 | Microbody |
| Component | GO:0042588 | Zymogen granule |
| Component | GO:0042995 | Cell projection |
| Component | GO:0043226 | Organelle |
| Component | GO:0043227 | Membrane-bounded organelle |
| Component | GO:0043229 | Intracellular organelle |
| Component | GO:0043230 | Extracellular organelle |
| Component | GO:0043231 | Intracellular membrane-bounded organelle |
| Component | GO:0043233 | Organelle lumen |
| Component | GO:0043235 | Receptor complex |
| Component | GO:0045121 | Membrane raft |
| Component | GO:0046696 | Lipopolysaccharide receptor complex |
| Component | GO:0065010 | Extracellular membrane-bounded organelle |
| Component | GO:0070013 | Intracellular organelle lumen |
| Component | GO:0070062 | Extracellular exosome |
| Component | GO:0071944 | Cell periphery |
| Component | GO:0097225 | Sperm midpiece |
| Component | GO:0097524 | Sperm plasma membrane |
| Component | GO:0097708 | Intracellular vesicle |
| Component | GO:0097729 | 9+2 motile cilium |
| Component | GO:0098590 | Plasma membrane region |
| Component | GO:0098791 | Golgi apparatus subcompartment |
| Component | GO:0098796 | Membrane protein complex |
| Component | GO:0098857 | Membrane microdomain |
| Component | GO:0099503 | Secretory vesicle |
| Component | GO:0110165 | Cellular anatomical entity |
| Component | GO:0120025 | Plasma membrane bounded cell projection |
| Component | GO:1903561 | Extracellular vesicle |
| Function | GO:0000166 | Nucleotide binding |
| Function | GO:0001530 | Lipopolysaccharide binding |
| Function | GO:0002039 | p53 binding |
| Function | GO:0003676 | Nucleic acid binding |
| Function | GO:0003723 | RNA binding |
| Function | GO:0003725 | Double-stranded RNA binding |
| Function | GO:0003824 | Catalytic activity |
| Function | GO:0005488 | Binding |
| Function | GO:0005515 | Protein binding |
| Function | GO:0005524 | ATP binding |
| Function | GO:0008035 | High-density lipoprotein particle binding |
| Function | GO:0008289 | Lipid binding |
| Function | GO:0016787 | Hydrolase activity |
| Function | GO:0016853 | Isomerase activity |
| Function | GO:0017076 | Purine nucleotide binding |
| Function | GO:0019899 | Enzyme binding |
| Function | GO:0030554 | Adenyl nucleotide binding |
| Function | GO:0031625 | Ubiquitin protein ligase binding |
| Function | GO:0032553 | Ribonucleotide binding |
| Function | GO:0032555 | Purine ribonucleotide binding |
| Function | GO:0032559 | Adenyl ribonucleotide binding |
| Function | GO:0034185 | Apolipoprotein binding |
| Function | GO:0034186 | Apolipoprotein A-I binding |
| Function | GO:0035639 | Purine ribonucleoside triphosphate binding |
| Function | GO:0036094 | Small molecule binding |
| Function | GO:0043167 | Ion binding |
| Function | GO:0043168 | Anion binding |
| Function | GO:0044183 | Protein folding chaperone |
| Function | GO:0044389 | Ubiquitin-like protein ligase binding |
| Function | GO:0044877 | Protein-containing complex binding |
| Function | GO:0051087 | Chaperone binding |
| Function | GO:0071813 | Lipoprotein particle binding |
| Function | GO:0071814 | Protein-lipid complex binding |
| Function | GO:0097159 | Organic cyclic compound binding |
| Function | GO:0097367 | Carbohydrate derivative binding |
| Function | GO:0140030 | Modification-dependent protein binding |
| Function | GO:0140657 | ATP-dependent activity |
| Function | GO:0140662 | ATP-dependent protein folding chaperone |
| Function | GO:1901265 | Nucleoside phosphate binding |
| Function | GO:1901363 | Heterocyclic compound binding |
Pathway annotation
| Category | Term ID | Term description |
|---|---|---|
| RCTM | RNO-1268020 | Mitochondrial protein import |
| RCTM | RNO-9609507 | Protein localization |
Expression profile of Hspd1 in omics data
| ID | GSE100499 |
| Title | Exploring acupuncture mechanism in preconditioning of IRI |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM2685201 | MX1 | tissue: Myocardium gender: male | 15.021809 |
| GSM2685202 | MX2 | tissue: Myocardium gender: female | 15.493864 |
| GSM2685203 | MX3 | tissue: Myocardium gender: female | 15.1888685 |
| GSM2685204 | MX4 | tissue: Myocardium gender: male | 15.010382 |
| GSM2685205 | DZ1 | tissue: Myocardium gender: male | 14.8261 |
| GSM2685206 | DZ2 | tissue: Myocardium gender: male | 15.043569 |
| GSM2685207 | DZ3 | tissue: Myocardium gender: female | 15.217809 |
| GSM2685208 | DZ4 | tissue: Myocardium gender: female | 15.105793 |
| GSM2685209 | JJ1 | tissue: Myocardium gender: male | 14.981047 |
| GSM2685210 | JJ2 | tissue: Myocardium gender: female | 15.041894 |
| GSM2685211 | JJ3 | tissue: Myocardium gender: female | 15.064131 |
| GSM2685212 | JJ4 | tissue: Myocardium gender: male | 14.889325 |
| GSM2685213 | NG1 | tissue: Myocardium gender: male | 14.750088 |
| GSM2685214 | NG2 | tissue: Myocardium gender: female | 15.036933 |
| GSM2685215 | NG3 | tissue: Myocardium gender: male | 14.819956 |
| GSM2685216 | NG4 | tissue: Myocardium gender: female | 14.746011 |
| GSM2685217 | YL1 | tissue: Myocardium gender: male | 15.258785 |
| GSM2685218 | YL2 | tissue: Myocardium gender: male | 15.008878 |
| GSM2685219 | YL3 | tissue: Myocardium gender: female | 14.923969 |
| GSM2685220 | YL4 | tissue: Myocardium gender: female | 14.976372 |
| GSM2685221 | QC1 | tissue: Myocardium gender: male | 15.297554 |
| GSM2685222 | QC2 | tissue: Myocardium gender: male | 15.443015 |
| GSM2685223 | QC3 | tissue: Myocardium gender: female | 15.436689 |
| GSM2685224 | QC4 | tissue: Myocardium gender: female | 15.082813 |
| ID | GSE136833 |
| Title | Effects of lidocaine on the expression of rat spinal cord |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM4058984 | Control_1 | strain: Sprague-Dawley tissue: Lumbar segment of spinal cord | 7.472105441 |
| GSM4058985 | Control_2 | strain: Sprague-Dawley tissue: Lumbar segment of spinal cord | 7.256206653 |
| GSM4058986 | Control_3 | strain: Sprague-Dawley tissue: Lumbar segment of spinal cord | 7.361104045 |
| GSM4058987 | Lidocaine_1 | strain: Sprague-Dawley tissue: Lumbar segment of spinal cord | 7.379670217 |
| GSM4058988 | Lidocaine_2 | strain: Sprague-Dawley tissue: Lumbar segment of spinal cord | 7.483581555 |
| GSM4058989 | Lidocaine_3 | strain: Sprague-Dawley tissue: Lumbar segment of spinal cord | 7.235171668 |
| ID | GSE138454 |
| Title | Impact of inflammation on hepatic subcellular energetics in anesthetized rats |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM4108997 | Sample 1 Isoflurane sepsis | anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male | 7174.0 |
| GSM4108998 | Sample 2 Isoflurane sepsis | anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male | 6061.0 |
| GSM4108999 | Sample 3 Isoflurane sepsis | anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male | 5848.0 |
| GSM4109000 | Sample 4 Isoflurane sepsis | anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male | 4161.0 |
| GSM4109001 | Sample 5 Isoflurane control | anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male | 6873.0 |
| GSM4109002 | Sample 6 Isoflurane control | anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male | 6852.0 |
| GSM4109003 | Sample 7 Isoflurane control | anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male | 6921.0 |
| GSM4109004 | Sample 8 Isoflurane control | anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male | 16085.0 |
| GSM4109005 | Sample9 Propofol sepsis | anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male | 9838.0 |
| GSM4109006 | Sample10 Propofol sepsis | anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male | 7804.0 |
| GSM4109007 | Sample11 Propofol sepsis | anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male | 7231.0 |
| GSM4109008 | Sample12 Propofol sepsis | anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male | 13234.0 |
| GSM4109009 | Sample13 Propofol control | anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male | 6066.0 |
| GSM4109010 | Sample14 Propofol control | anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male | 5936.0 |
| GSM4109011 | Sample 15 Propofol control | anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male | 8123.0 |
| GSM4109012 | Sample16 Propofol control | anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male | 7978.0 |
| ID | GSE139220 |
| Title | Expression data from sevoflurane anesthesia treated rat |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM4134285 | Brain_Control_rep1 | strain: Sprague-Dawley age: 18-month old treatment: control tissue: hippocampus | 8.811918 |
| GSM4134286 | Brain_Control_rep2 | strain: Sprague-Dawley age: 18-month old treatment: control tissue: hippocampus | 8.547111 |
| GSM4134287 | Brain_Control_rep3 | strain: Sprague-Dawley age: 18-month old treatment: control tissue: hippocampus | 8.619948 |
| GSM4134288 | Brain_Sevoflurane_rep1 | strain: Sprague-Dawley age: 18-month old treatment: sevoflurane anesthesia tissue: hippocampus | 8.315167 |
| GSM4134289 | Brain_Sevoflurane_rep2 | strain: Sprague-Dawley age: 18-month old treatment: sevoflurane anesthesia tissue: hippocampus | 8.822172 |
| GSM4134290 | Brain_Sevoflurane_rep3 | strain: Sprague-Dawley age: 18-month old treatment: sevoflurane anesthesia tissue: hippocampus | 8.819254 |
| ID | GSE143895 |
| Title | GPR160 de-orphanization reveals critical roles in neuropathic pain in rodents |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM4276356 | dhsc01 | strain: Sprague Dawley tissue: DHSC treatment: CCI | 154.628 |
| GSM4276357 | dhsc03 | strain: Sprague Dawley tissue: DHSC treatment: CCI | 152.882 |
| GSM4276358 | dhsc05 | strain: Sprague Dawley tissue: DHSC treatment: CCI | 144.618 |
| GSM4276359 | dhsc13 | strain: Sprague Dawley tissue: DHSC treatment: SHAM | 185.397 |
| GSM4276360 | dhsc15 | strain: Sprague Dawley tissue: DHSC treatment: SHAM | 157.198 |
| ID | GSE157924 |
| Title | Regulation of acupuncture on genes in brain stem |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM4780973 | Rattus_JSSZ(Sham) | tissue: Rattus brainstem of modeling treatment: Sham | 12.48181938 |
| GSM4780974 | Rattus_JXZ(Hand Acu) | tissue: Rattus brainstem of modeling treatment: Hand Acu | 12.50764208 |
| GSM4780975 | Rattus_MXZ(TBI) | tissue: Rattus brainstem of modeling treatment: TBI | 12.51009578 |
| ID | GSE1616 |
| Title | Genomics of preconditioning |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM27484 | APC_a (anesthetic-preconditioning, 1st replicate) | 4132.3 | |
| GSM27485 | APC_b (anesthetic-preconditioning, 2nd replicate) | 4035.933333333333 | |
| GSM27486 | APC_c (anesthetic-preconditioning, 3rd replicate) | 3131.3333333333335 | |
| GSM27487 | APC_d (anesthetic-preconditioning, 4th replicate) | 4952.166666666667 | |
| GSM27488 | APC_e (anesthetic-preconditioning, 5th replicate) | 4285.766666666666 | |
| GSM27489 | APC_TRI_a (trigger of anesthetic-preconditioning, 1st replicate) | 2313.2000000000003 | |
| GSM27490 | APC_TRI_b (trigger of anesthetic-preconditioning, 2nd replicate) | 2095.5666666666666 | |
| GSM27491 | APC_TRI_c (trigger of anesthetic-preconditioning, 3rd replicate) | 2610.233333333333 | |
| GSM27492 | APC_TRI_d (trigger of anesthetic-preconditioning, 4th replicate) | 2239.5666666666666 | |
| GSM27493 | APC_TRI_e (trigger of anesthetic-preconditioning, 5th replicate) | 1980.8 | |
| GSM27494 | CTL_a (control, 1st replicate) | 2750.4 | |
| GSM27495 | CTL_b (control, 2nd replicate) | 4395.8 | |
| GSM27496 | CTL_c (control, 3rd replicate) | 2638.6333333333337 | |
| GSM27497 | CTL_d (control, 4th replicate) | 3384.7999999999997 | |
| GSM27498 | CTL_e (control, 5th replicate) | 3185.7000000000003 | |
| GSM27499 | IPC_a (ischemic preconditioning, 1st replicate) | 5011.233333333334 | |
| GSM27500 | IPC_b (ischemic preconditioning, 2nd replicate) | 3818.2333333333336 | |
| GSM27501 | IPC_c (ischemic preconditioning, 3rd replicate) | 4575.333333333333 | |
| GSM27502 | IPC_d (ischemic preconditioning, 4th replicate) | 4999.900000000001 | |
| GSM27503 | IPC_e (ischemic preconditioning, 5th replicate) | 4440.266666666666 | |
| GSM27504 | IPC_TRI_a (trigger of ischemic preconditioning, 1st replicate) | 2687.2333333333336 | |
| GSM27505 | IPC_TRI_b (trigger of ischemic preconditioning, 2nd replicate) | 2848.7000000000003 | |
| GSM27506 | IPC_TRI_c (trigger of ischemic preconditioning, 3rd replicate) | 2913.5333333333333 | |
| GSM27507 | IPC_TRI_d (trigger of ischemic preconditioning, 4th replicate) | 2054.3333333333335 | |
| GSM27508 | IPC_TRI_e (trigger of ischemic preconditioning, 5th replicate) | 1707.0 | |
| GSM27509 | ISCH_a (ischemia, 1st replicate) | 2434.7000000000003 | |
| GSM27510 | ISCH_b (ischemia, 2nd replicate) | 4655.5 | |
| GSM27511 | ISCH_c (ischemia, 3rd replicate) | 5574.866666666666 | |
| GSM27512 | ISCH_d (ischemia, 4th replicate) | 5262.5 | |
| GSM27513 | ISCH_e (ischemia, 5th replicate) | 3585.4666666666667 |
| ID | GSE1779 |
| Title | Effect of Isoflurane and LTM on basolateral amygdala |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM30790 | baseline control 01 | male, 275-300g | 3630.3 |
| GSM30791 | baseline control 02 | male, 275-300g | 3487.3 |
| GSM30792 | baseline control 03 | male, 275-300g | 3803.4 |
| GSM30793 | baseline control 04 | male, 275-300g | 3471.4 |
| GSM30794 | baseline control 05 | male, 275-300g | 3686.8 |
| GSM30795 | baseline control 06 | male, 275-300g | 3604.9 |
| GSM30796 | baseline control 07 | male, 275-300g | 3561.0 |
| GSM30797 | baseline control 08 | male, 275-300g | 3836.9 |
| GSM30798 | baseline control 09 | male, 275-300g | 3866.0 |
| GSM30799 | pain 01 | 3373.3 | |
| GSM30800 | pain 02 | 3531.5 | |
| GSM30801 | pain 03 | 2976.9 | |
| GSM30802 | pain 04 | 3877.8 | |
| GSM30803 | pain 05 | 3925.0 | |
| GSM30804 | FC 01 | 3455.8 | |
| GSM30805 | FC 02 | 3367.1 | |
| GSM30806 | FC 03 | 3524.2 | |
| GSM30807 | FC 04 | 3664.5 | |
| GSM30808 | FC 05 | 3468.5 | |
| GSM30809 | IFC 01 | 3472.7 | |
| GSM30810 | IFC 02 | 3311.1 | |
| GSM30811 | IFC 03 | 3372.0 | |
| GSM30812 | IFC 04 | 3443.6 | |
| GSM30813 | IFC 05 | 4155.8 | |
| GSM99800 | isoflurane 01 | male, 275-300g | 3808.9 |
| GSM99801 | isoflurane 02 | male, 275-300g | 3335.4 |
| GSM99802 | isoflurane 03 | male, 275-300g | 3601.7 |
| GSM99803 | isoflurane 04 | male, 275-300g | 3328.6 |
| GSM99804 | isoflurane 05 | male, 275-300g | 3425.9 |
| ID | GSE190472 |
| Title | Study on VEGF regulation mechanism of acupuncture improving endometrial receptivity in IVF-ET |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM5724271 | model 21 | Sex: female tissue: Uterine tissue condition: model | 1068.9921 |
| GSM5724272 | model 22 | Sex: female tissue: Uterine tissue condition: model | 1116.5754 |
| GSM5724273 | model 23 | Sex: female tissue: Uterine tissue condition: model | 1121.2419 |
| GSM5724274 | treatment31 | Sex: female tissue: Uterine tissue condition: treatment | 1116.1987 |
| GSM5724275 | treatment32 | Sex: female tissue: Uterine tissue condition: treatment | 1238.106 |
| GSM5724276 | treatment33 | Sex: female tissue: Uterine tissue condition: treatment | 1131.6629 |
| GSM5724277 | control 41 | Sex: female tissue: Uterine tissue condition: control | 1082.1286 |
| GSM5724278 | control 42 | Sex: female tissue: Uterine tissue condition: control | 977.3725 |
| GSM5724279 | control 43 | Sex: female tissue: Uterine tissue condition: control | 1098.2446 |
| ID | GSE192399 |
| Title | Gene expression of brain regions activated by sevoflurane and propofol |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM5746332 | LHb, Sevoflurane, 60mins | brain region: the lateral habenula (LHb) treatment: Sevoflurane | 13.6638 |
| GSM5746333 | LHb, O2, 60mins | brain region: the lateral habenula (LHb) treatment: O2 | 13.5057 |
| GSM5746334 | MHb, Sevoflurane, 60mins | brain region: the medial habenula (MHb) treatment: Sevoflurane | 13.7626 |
| GSM5746335 | MHb, O2, 60mins | brain region: the medial habenula (MHb) treatment: O2 | 13.8124 |
| GSM5746336 | Sol, Sevoflurane, 60mins | brain region: the solitary nucleus (Sol) treatment: Sevoflurane | 13.5441 |
| GSM5746337 | Sol, O2, 60mins | brain region: the solitary nucleus (Sol) treatment: O2 | 13.6839 |
| GSM5746338 | Mve, Sevoflurane, 60mins | brain region: the medial vestibular nucleus (MVe) treatment: Sevoflurane | 14.0143 |
| GSM5746339 | Mve, O2, 60mins | brain region: the medial vestibular nucleus (MVe) treatment: O2 | 14.0873 |
| GSM5746340 | LHb, Propofol, 60mins | brain region: the lateral habenula (LHb) treatment: Propofol | 14.129 |
| GSM5746341 | LHb, Intralipos, 60mins | brain region: the lateral habenula (LHb) treatment: Intralipos | 14.2255 |
| GSM5746342 | MHb, Propofol, 60mins | brain region: the medial habenula (MHb) treatment: Propofol | 14.5084 |
| GSM5746343 | MHb, Intralipos, 60mins | brain region: the medial habenula (MHb) treatment: Intralipos | 14.3028 |
| GSM5746344 | Sol, Propofol, 60mins | brain region: the solitary nucleus (Sol) treatment: Propofol | 14.2394 |
| GSM5746345 | Sol, Intralipos, 60mins | brain region: the solitary nucleus (Sol) treatment: Intralipos | 14.1599 |
| GSM5746346 | MVe, Propofol, 60mins | brain region: the medial vestibular nucleus (MVe) treatment: Propofol | 14.4918 |
| GSM5746347 | MVe, Intralipos, 60mins | brain region: the medial vestibular nucleus (MVe) treatment: Intralipos | 14.6089 |
| ID | GSE232804 |
| Title | EGR3 regulates opioid-related nociception and motivation in male rats |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM7383519 | ww01_Saline_Saline | tissue: Brain / mPFC pain: Saline drug: Salin | 1949.0 |
| GSM7383520 | ww02_Saline_Saline | tissue: Brain / mPFC pain: Saline drug: Saline | 1995.0 |
| GSM7383521 | ww03_Saline_Saline | tissue: Brain / mPFC pain: Saline drug: Salin | 1846.0 |
| GSM7383522 | ww05_Saline_Saline | tissue: Brain / mPFC pain: Saline drug: Saline | 1735.0 |
| GSM7383523 | ww06_Saline_Saline | tissue: Brain / mPFC pain: Saline drug: Salin | 1820.0 |
| GSM7383524 | ww07_Saline_Saline | tissue: Brain / mPFC pain: Saline drug: Saline | 1486.0 |
| GSM7383525 | ww08_Saline_Saline | tissue: Brain / mPFC pain: Saline drug: Salin | 1961.0 |
| GSM7383526 | ww10_Saline_Saline | tissue: Brain / mPFC pain: Saline drug: Saline | 1627.0 |
| GSM7383527 | ww12_Saline_OXY | tissue: Brain / mPFC pain: Saline drug: OXY | 1382.0 |
| GSM7383528 | ww13_Saline_OXY | tissue: Brain / mPFC pain: Saline drug: OXY | 2675.0 |
| GSM7383529 | ww14_Saline_OXY | tissue: Brain / mPFC pain: Saline drug: OXY | 1796.0 |
| GSM7383530 | ww15_Saline_OXY | tissue: Brain / mPFC pain: Saline drug: OXY | 1872.0 |
| GSM7383531 | ww16_Saline_OXY | tissue: Brain / mPFC pain: Saline drug: OXY | 1853.0 |
| GSM7383532 | ww17_Saline_OXY | tissue: Brain / mPFC pain: Saline drug: OXY | 2605.0 |
| GSM7383533 | ww18_Saline_OXY | tissue: Brain / mPFC pain: Saline drug: OXY | 2497.0 |
| GSM7383534 | ww20_Saline_OXY | tissue: Brain / mPFC pain: Saline drug: OXY | 1334.0 |
| GSM7383535 | ww21_CFA_Saline | tissue: Brain / mPFC pain: CFA drug: Saline | 2108.0 |
| GSM7383536 | ww22_CFA_Saline | tissue: Brain / mPFC pain: CFA drug: Saline | 1943.0 |
| GSM7383537 | ww23_CFA_Saline | tissue: Brain / mPFC pain: CFA drug: Saline | 1283.0 |
| GSM7383538 | ww24_CFA_Saline | tissue: Brain / mPFC pain: CFA drug: Saline | 1207.0 |
| GSM7383539 | ww26_CFA_Saline | tissue: Brain / mPFC pain: CFA drug: Saline | 1840.0 |
| GSM7383540 | ww27_CFA_Saline | tissue: Brain / mPFC pain: CFA drug: Saline | 2850.0 |
| GSM7383541 | ww28_CFA_Saline | tissue: Brain / mPFC pain: CFA drug: Saline | 2231.0 |
| GSM7383542 | ww30_CFA_Saline | tissue: Brain / mPFC pain: CFA drug: Saline | 1969.0 |
| GSM7383543 | ww31_CFA_OXY | tissue: Brain / mPFC pain: CFA drug: OXY | 1918.0 |
| GSM7383544 | ww32_CFA_OXY | tissue: Brain / mPFC pain: CFA drug: OXY | 1134.0 |
| GSM7383545 | ww34_CFA_OXY | tissue: Brain / mPFC pain: CFA drug: OXY | 2025.0 |
| GSM7383546 | ww35_CFA_OXY | tissue: Brain / mPFC pain: CFA drug: OXY | 2095.0 |
| GSM7383547 | ww36_CFA_OXY | tissue: Brain / mPFC pain: CFA drug: OXY | 2300.0 |
| GSM7383548 | ww37_CFA_OXY | tissue: Brain / mPFC pain: CFA drug: OXY | 2471.0 |
| GSM7383549 | ww38_CFA_OXY | tissue: Brain / mPFC pain: CFA drug: OXY | 1977.0 |
| GSM7383550 | www09_Saline_Saline | tissue: Brain / mPFC pain: Saline drug: Saline | 2594.0 |
| GSM7383551 | www19_Saline_OXY | tissue: Brain / mPFC pain: Saline drug: OXY | 2282.0 |
| GSM7383552 | www29_CFA_Saline | tissue: Brain / mPFC pain: CFA drug: Saline | 1792.0 |
| GSM7383553 | www33_CFA_OXY | tissue: Brain / mPFC pain: CFA drug: OXY | 2273.0 |
| GSM7383554 | www39_CFA_OXY | tissue: Brain / mPFC pain: CFA drug: OXY | 1074.0 |
| ID | GSE244436 |
| Title | Similarity and dissimilarity in alteration of gene expression profile associated with inhalational anesthesia between sevoflurane and desflurane |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM7816143 | Liver, Control for SevoAnes | tissue: liver genotype: wild type treatment: Control for SevoAnes | 171.609482 |
| GSM7816144 | Liver, Anesthetized with sevoflurane for 6 h | tissue: liver genotype: wild type treatment: Anesthetized with sevoflurane for 6 h | 221.776779 |
| GSM7816145 | Liver, Control for DesAnes | tissue: liver genotype: wild type treatment: Control for DesAnes | 184.866241 |
| GSM7816146 | Liver, Anesthetized with desflurane for 6 h | tissue: liver genotype: wild type treatment: Anesthetized with desflurane for 6 h | 206.555908 |
| ID | GSE2982 |
| Title | Effect of inhaled anesthetic to cultured cortical neurons |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM61779 | Cell Culture Exposure (control1) | Cy3 label;Cy5; | -0.113 |
| GSM61796 | Cell Culture Exposure (control2) | Cy3; Cy5 | -0.00382 |
| GSM61797 | Cell Culture Exposure (control3) | Cy3; Cy5 | -0.134 |
| GSM61798 | Cell Culture Exposure (1MAC Halo1) | Cy3; Cy5 | -0.838 |
| GSM61799 | Cell Culture Exposure (1MAC Halo2) | Cy3; Cy5 | -0.091 |
| GSM61800 | Cell Culture Exposure (1MAC Halo3) | Cy3; Cy5 | -0.0382 |
| GSM61801 | Cell Culture Exposure (3MAC Halo1) | Cy3; Cy5 | -0.0805 |
| GSM61802 | Cell Culture Exposure (3MAC Halo2) | Cy3; Cy5 | -0.0399 |
| GSM61803 | Cell Culture Exposure (3MAC Halo3) | Cy3; Cy5 | -0.13 |
| GSM61804 | Cell Culture Exposure (3MAC ISO1) | Cy3; Cy5 | -0.119 |
| GSM61805 | Cell Culture Exposure (3MAC ISO2) | Cy3; Cy5 | -0.354 |
| GSM61806 | Cell Culture Exposure (3MAC ISO3) | Cy3; Cy5 | -0.0277 |
| ID | GSE359 |
| Title | Isoflurane Single Exposures |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM5120 | Isoflurane single exposure control-1 | 245.46666666666667 | |
| GSM5121 | Isoflurane single exposure control-2 | 330.2 | |
| GSM5122 | Isoflurane single exposure control-3 | 178.83333333333334 | |
| GSM5124 | Isoflurane single exposure 1 hr-1 | 284.93333333333334 | |
| GSM5126 | Isoflurane single exposure 1 hr-2 | 184.29999999999998 | |
| GSM5127 | Isoflurane single exposure 2 hr-1 | 415.1666666666667 | |
| GSM5130 | Isoflurane single exposure 2 hr-2 | 165.66666666666666 | |
| GSM5131 | Isoflurane single exposure 2 hr-3 | 225.4 |
| ID | GSE48025 |
| Title | Affymetrix Chip Data of the Transcriptome of the Rheumatoid Arthritis Rat Model Treated with Acupuncture (Affymetrix, mRNA, batch1) |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM1165929 | RAT_NORA_T0_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats before therapy | 10.53762736 |
| GSM1165930 | RAT_NORA_T0_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats before therapy | 10.51334779 |
| GSM1165931 | RAT_RA_T0_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats before therapy | 10.36404967 |
| GSM1165932 | RAT_RA_T0_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats before therapy | 10.44849154 |
| GSM1165933 | RAT_NORA_1h_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 1 hour after therapy | 10.56075538 |
| GSM1165934 | RAT_NORA_1h_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 1 hour after therapy | 10.1323402 |
| GSM1165935 | RAT_AP_1h_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour acupuncture therapy | 9.871791433 |
| GSM1165936 | RAT_AP_1h_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour acupuncture therapy | 10.47005845 |
| GSM1165937 | RAT_MTX_1h_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour MTX therapy | 10.36166712 |
| GSM1165938 | RAT_MTX_1h_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour MTX therapy | 10.55971076 |
| GSM1165939 | RAT_ANE_1h_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour ANE therapy | 10.5739501 |
| GSM1165940 | RAT_ANE_1h_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour ANE therapy | 9.859695715 |
| GSM1165941 | RAT_PLA_1h_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour placebo therapy | 10.34970365 |
| GSM1165942 | RAT_PLA_1h_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour placebo therapy | 9.872933671 |
| GSM1165943 | RAT_NORA_34d_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 34 days after therapy | 10.22959336 |
| GSM1165944 | RAT_NORA_34d_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 34 days after therapy | 10.11653703 |
| GSM1165945 | RAT_AP_34d_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days acupuncture therapy | 9.705610365 |
| GSM1165946 | RAT_AP_34d_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days acupuncture therapy | 10.08963951 |
| GSM1165947 | RAT_MTX_34d_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days MTX therapy | 10.09116898 |
| GSM1165948 | RAT_MTX_34d_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days MTX therapy | 10.22266723 |
| GSM1165949 | RAT_ANE_34d_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days ANE therapy | 10.16719075 |
| GSM1165950 | RAT_ANE_34d_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days ANE therapy | 10.35379869 |
| GSM1165951 | RAT_PLA_34d_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days placebo therapy | 10.2038559 |
| GSM1165952 | RAT_PLA_34d_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days placebo therapy | 10.2534481 |
| ID | GSE53897 |
| Title | Genome-wide analysis of dorsal root ganglion (DRG) gene expression after morphine or oxycodone treatment |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM1303240 | DRG RVM1 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 12.143297 |
| GSM1303241 | DRG RVM2 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 12.218666 |
| GSM1303242 | DRG RVM3 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 12.127713 |
| GSM1303243 | DRG RVM7 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 12.407911 |
| GSM1303244 | DRG RVOx2 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 12.444133 |
| GSM1303245 | DRG RVOx3 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 12.195933 |
| GSM1303246 | DRG RVOx5 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 12.308366 |
| GSM1303247 | DRG RVOx7 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 12.0046 |
| GSM1303248 | DRG RVS4 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 12.06573 |
| GSM1303249 | DRG RVS5 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 12.225414 |
| GSM1303250 | DRG RVS6 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 12.157688 |
| GSM1303251 | DRG RVS7 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 11.924045 |
| GSM1303252 | DRG RSM1 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 12.28313 |
| GSM1303253 | DRG RSM2 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 12.182429 |
| GSM1303254 | DRG RSM4 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 12.238159 |
| GSM1303255 | DRG RSM5 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 12.225414 |
| GSM1303256 | DRG RSOx1 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 12.481683 |
| GSM1303257 | DRG RSOx2 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 12.172262 |
| GSM1303258 | DRG RSOx3 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 12.329797 |
| GSM1303259 | DRG RSOx4 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 12.215963 |
| GSM1303260 | DRG RSS1 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 12.25635 |
| GSM1303261 | DRG RSS2 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 12.08639 |
| GSM1303262 | DRG RSS3 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 12.117743 |
| GSM1303263 | DRG RSS6 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 12.188228 |
| ID | GSE55573 |
| Title | Using DNA microarray to screen intracellular signal pathways of hypoglycemic activity by electroacupuncture of Zusanli (ST36) acupoints in streptozotocin-induced rats with diabetes |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM1339443 | Mock skeletal muscle | strain: Wistar age: 8-10 week-old gender: Male | 3227.8406 |
| GSM1339444 | EA (electroacupuncture) skeletal muscle | strain: Wistar age: 8-10 week-old gender: Male | 3326.1042 |
| ID | GSE58456 |
| Title | Affymetrix Chip Data of the Transcriptome of the Rheumatoid Arthritis Rat Model Treated with Acupuncture (Affymetrix, mRNA, batch 2) |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM1693996 | Peripheral blood mononuclear cells from NORA before therapy, replicate 1 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therapy | 4573.5239 |
| GSM1693997 | Peripheral blood mononuclear cells from NORA before therapy, replicate 2 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therapy | 4828.260509 |
| GSM1693998 | Peripheral blood mononuclear cells from NORA before therapy, replicate 3 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therapy | 2980.061697 |
| GSM1693999 | Peripheral blood mononuclear cells from RA before therapy, replicate 1 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats before therapy | 5180.875682 |
| GSM1694000 | Peripheral blood mononuclear cells from RA before therapy, replicate 2 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats before therapy | 4734.385118 |
| GSM1694001 | Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 1 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therapy | 3972.650602 |
| GSM1694002 | Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 2 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therapy | 4908.454308 |
| GSM1694003 | Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 3 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therapy | 4729.746801 |
| GSM1694004 | Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 1 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy | 3733.637984 |
| GSM1694005 | Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 2 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy | 4237.059506 |
| GSM1694006 | Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 3 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy | 4893.571209 |
| GSM1694007 | Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 1 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy | 3719.169544 |
| GSM1694008 | Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 2 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy | 3387.759789 |
| GSM1694009 | Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 3 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy | 5853.48828 |
| ID | GSE58460 |
| Title | Rheumatoid Arthritis Rat Model Treated with Acupuncture |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM1165929 | RAT_NORA_T0_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats before therapy | 10.53762736 |
| GSM1165930 | RAT_NORA_T0_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats before therapy | 10.51334779 |
| GSM1165931 | RAT_RA_T0_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats before therapy | 10.36404967 |
| GSM1165932 | RAT_RA_T0_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats before therapy | 10.44849154 |
| GSM1165933 | RAT_NORA_1h_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 1 hour after therapy | 10.56075538 |
| GSM1165934 | RAT_NORA_1h_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 1 hour after therapy | 10.1323402 |
| GSM1165935 | RAT_AP_1h_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour acupuncture therapy | 9.871791433 |
| GSM1165936 | RAT_AP_1h_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour acupuncture therapy | 10.47005845 |
| GSM1165937 | RAT_MTX_1h_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour MTX therapy | 10.36166712 |
| GSM1165938 | RAT_MTX_1h_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour MTX therapy | 10.55971076 |
| GSM1165939 | RAT_ANE_1h_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour ANE therapy | 10.5739501 |
| GSM1165940 | RAT_ANE_1h_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour ANE therapy | 9.859695715 |
| GSM1165941 | RAT_PLA_1h_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour placebo therapy | 10.34970365 |
| GSM1165942 | RAT_PLA_1h_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour placebo therapy | 9.872933671 |
| GSM1165943 | RAT_NORA_34d_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 34 days after therapy | 10.22959336 |
| GSM1165944 | RAT_NORA_34d_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 34 days after therapy | 10.11653703 |
| GSM1165945 | RAT_AP_34d_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days acupuncture therapy | 9.705610365 |
| GSM1165946 | RAT_AP_34d_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days acupuncture therapy | 10.08963951 |
| GSM1165947 | RAT_MTX_34d_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days MTX therapy | 10.09116898 |
| GSM1165948 | RAT_MTX_34d_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days MTX therapy | 10.22266723 |
| GSM1165949 | RAT_ANE_34d_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days ANE therapy | 10.16719075 |
| GSM1165950 | RAT_ANE_34d_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days ANE therapy | 10.35379869 |
| GSM1165951 | RAT_PLA_34d_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days placebo therapy | 10.2038559 |
| GSM1165952 | RAT_PLA_34d_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days placebo therapy | 10.2534481 |
| GSM1412003 | RAT_NORA_T0_1 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412004 | RAT_NORA_T0_2 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412005 | RAT_RA_T0_1 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412006 | RAT_RA_T0_2 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412007 | RAT_NORA_1h_1 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412008 | RAT_NORA_1h_2 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412009 | RAT_AP_1h_1 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412010 | RAT_AP_1h_2 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412011 | RAT_MTX_1h_1 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412012 | RAT_MTX_1h_2 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412013 | RAT_ANE_1h_1 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412014 | RAT_ANE_1h_2 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412015 | RAT_PLA_1h_1 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412016 | RAT_PLA_1h_2 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412017 | RAT_NORA_34d_1 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412018 | RAT_NORA_34d_2 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412019 | RAT_AP_34d_1 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412020 | RAT_AP_34d_2 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412021 | RAT_MTX_34d_1 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412022 | RAT_MTX_34d_2 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412023 | RAT_ANE_34d_1 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412024 | RAT_ANE_34d_2 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412025 | RAT_PLA_34d_1 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412026 | RAT_PLA_34d_2 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412027 | RAT_RA_T0_1 | strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue | |
| GSM1412028 | RAT_RA_T0_2 | strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue | |
| GSM1412029 | RAT_AP_1h_1 | strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue | |
| GSM1412030 | RAT_AP_1h_2 | strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue | |
| GSM1412031 | RAT_PLA_1h_1 | strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue | |
| GSM1412032 | RAT_PLA_1h_2 | strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue | |
| GSM1412033 | RAT_AP_34d_1 | strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue | |
| GSM1412034 | RAT_AP_34d_2 | strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue | |
| GSM1412035 | RAT_PLA_34d_1 | strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue | |
| GSM1412036 | RAT_PLA_34d_2 | strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue | |
| GSM1693996 | Peripheral blood mononuclear cells from NORA before therapy, replicate 1 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therap | 4573.5239 |
| GSM1693997 | Peripheral blood mononuclear cells from NORA before therapy, replicate 2 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therapy | 4828.260509 |
| GSM1693998 | Peripheral blood mononuclear cells from NORA before therapy, replicate 3 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therapy | 2980.061697 |
| GSM1693999 | Peripheral blood mononuclear cells from RA before therapy, replicate 1 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats before therapy | 5180.875682 |
| GSM1694000 | Peripheral blood mononuclear cells from RA before therapy, replicate 2 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats before therapy | 4734.385118 |
| GSM1694001 | Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 1 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therapy | 3972.650602 |
| GSM1694002 | Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 2 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therap | 4908.454308 |
| GSM1694003 | Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 3 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therapy | 4729.746801 |
| GSM1694004 | Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 1 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy | 3733.637984 |
| GSM1694005 | Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 2 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy | 4237.059506 |
| GSM1694006 | Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 3 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy | 4893.571209 |
| GSM1694007 | Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 1 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy | 3719.169544 |
| GSM1694008 | Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 2 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy | 3387.759789 |
| GSM1694009 | Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 3 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy | 5853.48828 |
| ID | GSE752 |
| Title | Halothane/Isoflurane Repetitive Exposures |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM5082 | Control 1 | 506.3666666666666 | |
| GSM5084 | Control 2 | 479.5333333333333 | |
| GSM5085 | Control 3 | 467.7 | |
| GSM5086 | Control 4 | 476.5333333333333 | |
| GSM5087 | Control 5 | 579.0333333333334 | |
| GSM5090 | Control 6 | 453.93333333333334 | |
| GSM5105 | Control 7 | 535.5333333333333 | |
| GSM5106 | Control 8 | 508.03333333333336 | |
| GSM5107 | Control 9 | 510.2333333333333 | |
| GSM5108 | Halothane 10 exposure-1 | 579.7666666666668 | |
| GSM5109 | Halothane 10 exposures-2 | 630.7666666666668 | |
| GSM5110 | Halothane 10 exposures-3 | 418.5333333333333 | |
| GSM5111 | Halothane 5 exposures-1 | 625.8000000000001 | |
| GSM5112 | Halothane 5 exposures-2 | 533.3333333333334 | |
| GSM5113 | Halothane 5 exposures-3 | 443.8333333333333 | |
| GSM5114 | Isoflurane 10 exposures-1 | 547.1666666666666 | |
| GSM5115 | Isoflurane 10 exposures-2 | 500.0 | |
| GSM5116 | Isoflurane 10 exposures-3 | 442.4666666666667 | |
| GSM5117 | Isoflurane 5 exposures-1 | 479.6666666666667 | |
| GSM5118 | Isoflurane 5 exposures-2 | 522.9333333333334 | |
| GSM5119 | Isoflurane 5 exposures-3 | 401.06666666666666 | |
| GSM11379 | Control 10 | 498.0666666666666 | |
| GSM11380 | Control 11 | 453.43333333333334 | |
| GSM11381 | Control 12 | 506.4666666666667 |
| ID | GSE8911 |
| Title | Skeletal muscle after fine needle stimulation |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM225891 | Skeletal muscle sample from fine needle-stimulated hindlimb | Strain: Lewis, Gender: Male, Body Weight: 275g, Tissue: Skeletal muscle sample from fine nnedle-stimulated hindlimb | 1251.46 |
| GSM225892 | Skeletal muscle sample from control hindlimb | Strain: Lewis, Gender: Male, Body weight: 275g, Tissue: skeletal muscle sample from non fine needle-stimulated hindlimb | 1178.93 |
